Form 4: Labcorp Executive Amy B. Summy Reports Stock Sale Under 10b5-1 Plan

Amy B. Summy, EVP and Chief Marketing Officer of Labcorp, reports the sale of 226 shares of common stock at $250.4 per share on February 24, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• On February 24, 2025, Amy B. Summy, the EVP and Chief Marketing Officer of LABCORP HOLDINGS INC. [LH], sold 226 shares of common stock.
• The sale was executed at a price of $250.4 per share.
• The transaction was conducted under a pre-arranged trading plan in accordance with Rule 10b5-1.
• Following the transaction, Ms. Summy directly owns 4,544.5 shares of Labcorp common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing a stock sale by an executive under a pre-arranged plan. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on any specific non-public information.

Stakeholder Impact

• The stock sale may have a minor impact on shareholders, but the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates